News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,647 Results
Type
Article (485)
Company Profile (13)
Press Release (23149)
Section
Business (10927)
Career Advice (15)
Deals (1870)
Drug Development (2289)
Employer Resources (1)
FDA (509)
Job Trends (718)
News (14862)
Policy (963)
Tag
Academia (69)
Allergies (6)
Alliances (965)
ALS (2)
Alzheimer's disease (27)
Antibody-drug conjugate (ADC) (1)
Approvals (520)
Artificial intelligence (1)
Bankruptcy (4)
Best Places to Work (714)
BIOSECURE Act (1)
Biosimilars (1)
Biotechnology (9)
Bladder cancer (6)
Breast cancer (8)
Cancer (62)
Cardiovascular disease (4)
Career advice (11)
Career pathing (2)
CAR-T (3)
Cell therapy (21)
Clinical research (1997)
Collaboration (14)
Compensation (7)
COVID-19 (106)
CRISPR (3)
C-suite (3)
Cystic fibrosis (1)
Data (115)
Depression (1)
Diabetes (6)
Diagnostics (219)
Digital health (1)
Drug discovery (1)
Duchenne muscular dystrophy (2)
Earnings (9287)
Editorial (2)
Employer resources (1)
Events (3258)
Executive appointments (7)
FDA (577)
Funding (16)
Gene editing (3)
Gene therapy (5)
GLP-1 (14)
Government (172)
Guidances (29)
Healthcare (938)
Huntington's disease (1)
Immunology and inflammation (2)
Indications (1)
Infectious disease (112)
Inflammatory bowel disease (7)
Influenza (2)
Intellectual property (1)
Interviews (1)
IPO (1402)
Job creations (45)
Job search strategy (5)
Kidney cancer (1)
Labor market (2)
Layoffs (8)
Legal (135)
Liver cancer (4)
Lung cancer (8)
Lymphoma (3)
Manufacturing (6)
Medical device (662)
Medtech (662)
Mergers & acquisitions (487)
Metabolic disorders (14)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (3)
Neuroscience (39)
NextGen: Class of 2025 (181)
Non-profit (112)
Obesity (9)
Opinion (1)
Ovarian cancer (3)
Pain (2)
Pancreatic cancer (1)
Parkinson's disease (1)
Partnered (2)
Patents (1)
Patient recruitment (1)
Peanut (5)
People (977)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (461)
Phase II (739)
Phase III (927)
Pipeline (173)
Policy (1)
Postmarket research (101)
Preclinical (151)
Press Release (3)
Prostate cancer (3)
Radiopharmaceuticals (10)
Rare diseases (12)
Real estate (85)
Recruiting (1)
Regulatory (718)
Reports (3)
Research institute (49)
Resumes & cover letters (7)
RSV (3)
Schizophrenia (1)
Series B (2)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (43)
State (1)
Vaccines (19)
Venture capitalists (2)
Weight loss (3)
Women's health (4)
Date
Last 7 days (64)
Last 30 days (139)
Last 365 days (1426)
2025 (525)
2024 (1608)
2023 (1820)
2022 (1992)
2021 (2005)
2020 (5526)
2019 (1415)
2018 (1108)
2017 (827)
2016 (559)
2015 (806)
2014 (616)
2013 (394)
2012 (447)
2011 (567)
2010 (476)
Location
Africa (6)
Alabama (2)
Arizona (4)
Asia (1592)
Australia (102)
California (243)
Canada (74)
China (11)
Colorado (11)
Connecticut (8)
Delaware (17)
Europe (2922)
Florida (39)
Georgia (10)
Idaho (1)
Illinois (23)
India (1)
Indiana (16)
Japan (7)
Kansas (1)
Kentucky (1)
Louisiana (2)
Maine (6)
Maryland (36)
Massachusetts (208)
Michigan (15)
Minnesota (15)
Missouri (6)
Montana (2)
Nevada (2)
New Hampshire (2)
New Jersey (101)
New York (74)
North Carolina (43)
Northern California (121)
Ohio (5)
Oregon (1)
Pennsylvania (140)
Rhode Island (1)
South America (26)
Southern California (93)
Tennessee (2)
Texas (27)
United States (1065)
Utah (11)
Virginia (4)
Washington State (24)
Wisconsin (2)
23,647 Results for "215".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
April 15, 2025
·
3 min read
Press Releases
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
May 8, 2025
·
4 min read
Press Releases
Portage Biotech Announces Completion of $2.15 Million Private Financing
January 30, 2025
·
2 min read
Press Releases
Cancer Biologics Market Size to Increase by 7.66% CAGR to Hit USD 215.60 Bn by 2033
February 18, 2025
·
1 min read
Press Releases
Colorado’s Life Sciences Ecosystem Raised $2.15 Billion in 2024
Fundraising Exceeds $2B for the Second Time in Four-Year Period
December 19, 2024
·
1 min read
Press Releases
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
March 25, 2025
·
4 min read
Press Releases
ScribeEMR to Highlight AI Scribing and Virtual Coding Advances at the National Association of Community Health Center’s Policy & Issues Forum (Booth 215)
January 30, 2025
·
1 min read
Press Releases
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
November 13, 2024
·
6 min read
Business
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a continued appetite for these drugs.
November 13, 2024
·
2 min read
·
Kate Goodwin
Pharm Country
MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024MiNK-215 Eradicated Tumor Cells in Human Organoid MSS Colorectal Cancer Liver Metastases Model
MiNK Therapeutics, Inc. today announced the presentation of preclinical data from MiNK-215, an IL-15 armored FAP-targeting CAR-iNKT cell therapy, at the upcoming AACR Meeting, to be held April 5 – 10, 2024.
March 6, 2024
·
4 min read
1 of 2,365
Next
